Martina Müller-Nurasyid Selected Research

Martina Müller-Nurasyid Research Topics

Disease

9	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022 - 01/2011
7	Obesity 07/2019 - 10/2014
6	Atrial Fibrillation 01/2020 - 04/2014
5	Type 2 Diabetes Mellitus (MODY) 01/2020 - 11/2013
3	Insulin Resistance 01/2020 - 09/2012
3	Coronary Disease (Coronary Heart Disease) 01/2017 - 01/2016
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2017 - 01/2011
3	Atherosclerosis 01/2017 - 01/2011
2	Brugada Syndrome 05/2022 - 01/2022
2	Disease Susceptibility (Diathesis) 05/2022 - 01/2022
2	Heart Failure 01/2021 - 01/2018
2	Myocardial Infarction 01/2021 - 01/2016
2	Genetic Predisposition to Disease (Genetic Predisposition) 01/2020 - 02/2016
2	Atopic Dermatitis (Atopic Eczema) 01/2020 - 12/2011
2	Stroke (Strokes) 01/2018 - 02/2016
2	Cardiac Sudden Death (Sudden Cardiac Arrest) 01/2018 - 03/2014
2	Atherosclerotic Plaque (Atheroma) 01/2017 - 01/2011
1	Aortic Valve Stenosis (Aortic Stenosis) 01/2022
1	Peripheral Arterial Disease 01/2022
1	Sudden Death 01/2022
1	Multiple System Atrophy 01/2021
1	Glucose Intolerance 01/2021
1	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2021
1	Anorexia Nervosa 01/2021
1	Inflammatory Bowel Diseases (Inflammatory Bowel Disease) 01/2021
1	Thrombosis (Thrombus) 01/2021
1	Infarction (Infarctions) 01/2021
1	ST Elevation Myocardial Infarction 01/2021
1	Parkinson Disease (Parkinson's Disease) 01/2020
1	Neoplasms (Cancer) 01/2020
1	Adenocarcinoma 01/2020
1	Cardiac Arrhythmias (Arrythmia) 01/2020
1	Kidney Diseases (Kidney Disease) 11/2019
1	Gout 10/2019
1	Atrial Flutter (Flutter, Atrial) 12/2018
1	Ischemic Stroke 01/2018
1	beta-Thalassemia (Cooley's Anemia) 12/2017
1	Macular Degeneration (Age-Related Maculopathy) 12/2017
1	Glucosephosphate Dehydrogenase Deficiency 09/2017
1	Hypernatremia 08/2017
1	Growth Disorders 01/2017
1	Genetic Risk Score 01/2017
1	Breast Neoplasms (Breast Cancer) 11/2015
1	Systemic Lupus Erythematosus (Libman-Sacks Disease) 07/2015
1	Autoimmune Diseases (Autoimmune Disease) 07/2015

Drug/Important Bio-Agent (IBA)

7	Proteins (Proteins, Gene)FDA Link 01/2021 - 01/2011
5	Insulin (Novolin)FDA Link 01/2021 - 09/2012
4	Glucose (Dextrose)FDA LinkGeneric 01/2021 - 01/2016
4	LipidsIBA 11/2018 - 09/2012
3	Biological ProductsIBA 01/2021 - 01/2017
3	Biomarkers (Surrogate Marker)IBA 01/2020 - 01/2011
3	Lipoproteins (Lipoprotein)IBA 12/2017 - 11/2013
3	Triglycerides (Triacylglycerol)IBA 01/2016 - 11/2013
2	Phytosterols (Plant Sterols)IBA 10/2022 - 02/2022
2	Sodium Channels (Sodium Channel)IBA 05/2022 - 01/2022
2	SynucleinsIBA 01/2021 - 01/2020
2	Filaggrin ProteinsIBA 01/2020 - 12/2011
2	Genetic Markers (Genetic Marker)IBA 12/2017 - 04/2014
2	Pharmaceutical PreparationsIBA 06/2017 - 01/2016
2	HDL CholesterolIBA 03/2016 - 11/2013
1	Lipoprotein(a)IBA 01/2022
1	Ethylnitrosourea (N-Ethyl-N-nitrosourea)IBA 01/2022
1	Deoxyribonucleases (DNase)FDA Link 01/2021
1	Cell-Free Nucleic AcidsIBA 01/2021
1	Interleukin-13IBA 01/2020
1	Interleukin-6 Receptors (Interleukin 6 Receptor)IBA 01/2020
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2020
1	AlbuminsIBA 11/2019
1	CreatinineIBA 11/2019
1	Uric Acid (Urate)IBA 10/2019
1	activated protein C receptorIBA 01/2018
1	ThrombomodulinIBA 01/2018
1	Protein CIBA 01/2018
1	Endothelial Protein C ReceptorIBA 01/2018
1	oxidized low density lipoproteinIBA 12/2017
1	Hemoglobins (Hemoglobin)IBA 09/2017
1	Glycated Hemoglobin (Glycosylated Hemoglobin)IBA 09/2017
1	ElectrolytesIBA 08/2017
1	Proteoglycans (Proteoglycan)IBA 01/2017
1	GlycosaminoglycansIBA 01/2017
1	EnzymesIBA 01/2017
1	Peptide Hydrolases (Proteases)FDA Link 01/2017
1	HomocysteineIBA 01/2017
1	1-Alkyl-2-acetylglycerophosphocholine Esterase (PAF Acetylhydrolase)IBA 01/2017
1	darapladibIBA 01/2017
1	Scavenger Receptors (Scavenger Receptor)IBA 03/2016
1	Serine Proteases (Serine Protease)IBA 02/2016
1	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2016
1	P-2 (P 2)IBA 01/2016
1	DNA (Deoxyribonucleic Acid)IBA 01/2016
1	AngiopoietinsIBA 01/2016
1	Gonadal Steroid Hormones (Sex Hormones)IBA 11/2015
1	HLA-DQ Antigens (HLA-DQ)IBA 07/2015
1	micaIBA 07/2015
1	InterferonsIBA 07/2015
1	MorpholinosIBA 05/2015

Therapy/Procedure

2	Therapeutics 01/2020 - 01/2020
1	Percutaneous Coronary Intervention 01/2021
1	Catheter Ablation 12/2018
1	Glycemic Control 09/2017